Promestriene API: Understanding CAS 39219-28-8 for Pharmaceutical Applications
Discover the therapeutic potential of Promestriene, a key synthetic estrogen analog for women's health.
Get a Quote & SampleProduct Core Value
Promestriene
Promestriene (CAS 39219-28-8) is a synthetic estrogen analog designed for local application, primarily in the treatment of conditions like atrophic vaginitis and other estrogen deficiency-related disorders. Its mechanism involves binding to estrogen receptors in urogenital tissues, promoting cellular responses that restore normal tissue structure and function. This leads to improved vaginal lubrication, elasticity, and maintenance of a healthy vaginal pH, which helps prevent pathogenic bacterial and fungal overgrowth.
- Exploring the synthetic estrogen for vaginal atrophy benefits, Promestriene aids in alleviating symptoms like dryness, itching, and discomfort.
- Understanding the CAS 39219-28-8 mechanism of action reveals its targeted approach to estrogen receptors, minimizing systemic effects.
- The Promestriene treatment for postmenopausal symptoms offers a localized solution, improving the quality of life for many women.
- This API serves as a valuable alternative to systemic estrogen replacement therapy, offering a favorable safety profile for targeted applications.
Key Product Advantages
Targeted Local Action
Promestriene's local application minimizes systemic absorption, reducing the risk of systemic side effects commonly associated with oral estrogen therapies, a key aspect of its women's health pharmaceuticals profile.
Effective Symptom Relief
It effectively addresses symptoms of vaginal atrophy and urogenital atrophy, significantly improving patients' quality of life through its restorative properties.
pH Balance and Infection Prevention
By promoting glycogen production in vaginal epithelial cells, Promestriene supports the natural metabolic processes that maintain an acidic vaginal pH, crucial for preventing infections.
Key Applications
Atrophic Vaginitis Treatment
Utilizing Promestriene's ability to restore vaginal mucosa, this application directly addresses inflammation and thinning of vaginal tissues.
Urogenital Atrophy Management
Promestriene supports the regeneration of epithelial cells in the urogenital tract, alleviating discomfort and improving function.
Postmenopausal Health Support
As part of the growing field of menopause symptom management, Promestriene offers localized relief for issues stemming from decreased estrogen levels.
Estrogen Receptor Modulation
The compound's mechanism as an estrogen receptor modulator makes it valuable in specific therapeutic contexts within women's health.